Pacira BioSciences Inc

PCRX NASDAQ
38.27
+0.05
+0.13%
Opening 12:53 08/19 EDT
Open
38.66
Prev Close
38.22
High
38.67
Low
38.17
Volume
104.59K
Avg Vol (3M)
510.14K
52 Week High
55.00
52 Week Low
35.07
% Turnover
0.25%
Market Cap
1.59B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Pacira BioSciences Inc PCRX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Pacira BioSciences, Inc., formerly Pacira Pharmaceuticals, Inc. is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its DepoFoam extended release drug delivery technology, for use primarily in hospitals and ambulatory surgery centers. Its lead product candidate is EXPAREL (bupivacaine liposome injectable suspension), which consists of bupivacaine, an amide-type local anesthetic, encapsulated in DepoFoam and is indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. In addition to EXPAREL, DepoFoam is also the basis for its other Food and Drug Administration-approved commercial product, DepoCyt(e), which it manufactures for its commercial partners, as well as its product candidates. The Company's other product candidates include DepoMeloxicam (DepoMLX) and DepoTranexamic Acid (DepoTXA).
MORE >

Recently

Name
Price
%Change